1. AniScan Using Extracellular Cyclic AMP-Dependent Protein Kinase A as a Serum Biomarker Assay for the Diagnosis of Malignant Tumors in Dogs
- Author
-
Ul Soo Choi, Changsun Lee, Hun-joo Lee, Ji Eun Lee, Dong Ha Bhang, Bonghwan Jang, Byung-Gak Kim, Tae Ho Kim, Hwa-Young Youn, and Woo-Jin Song
- Subjects
Male ,tumor ,Letter ,040301 veterinary sciences ,Diagnostic accuracy ,lcsh:Chemical technology ,Biochemistry ,Immunoglobulin G ,Analytical Chemistry ,0403 veterinary science ,03 medical and health sciences ,0302 clinical medicine ,Dogs ,Serum biomarkers ,Neoplasms ,Republic of Korea ,Extracellular ,Biomarkers, Tumor ,Cyclic AMP ,Medicine ,Animals ,cancer ,lcsh:TP1-1185 ,Dog Diseases ,Electrical and Electronic Engineering ,Protein kinase A ,Instrumentation ,Routine screening ,biology ,business.industry ,Autoantibody ,04 agricultural and veterinary sciences ,Cyclic AMP-Dependent Protein Kinases ,Atomic and Molecular Physics, and Optics ,extracellular c-AMP-dependent protein kinase A ,030220 oncology & carcinogenesis ,dog ,Cancer research ,biology.protein ,Biomarker (medicine) ,biomarker ,Female ,business - Abstract
The early detection of tumors improves chances of decreased morbidity and prolonged survival. Serum biomarkers are convenient to use and have several advantages over other approaches, such as accuracy and straightforward protocols. Reliable biomarkers from easily accessible sources are warranted for the development of cost-effective assays for routine screening, particularly in veterinary medicine. Extracellular c-AMP-dependent protein kinase A (ECPKA) is a cytosolic leakage enzyme. The diagnostic accuracy of detecting autoantibodies against ECPKA was found to be higher than that of ECPKA activity from enzymatic assays, which use a complicated method. Here, we investigated the diagnostic significance of measuring serum ECPKA autoantibody levels using an in-house kit (AniScan cancer detection kit; Biattic, Anyang, Korea). We used sera from 550 dogs, including healthy dogs and those with malignant and benign tumors. Serum ECPKA and immunoglobulin G were determined using the AniScan cancer detection kit. ECPKA autoantibody levels were significantly higher (p < 0.01) in malignant tumors than in benign tumors, non-tumor diseases, and healthy controls. On the basis of sensitivity and specificity values, AniScan ECPKA is a rapid and easy-to-use assay that can be applied to screen malignant tumors from benign tumors or other diseases in dogs.
- Published
- 2020